Thyrocare Technologies Ltd reports Q2 FY27 consolidated revenue of ₹270.81 crore, up 25.1% YoY, and net profit of ₹15.22 crore after impairment charge.
- Revenue rose 12.8% sequentially; operating margin was approximately 29.3%.
- Net profit fell 68.2% YoY and 70.4% QoQ, including a ₹44.98 crore exceptional impairment charge.
- Board approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026; auditors issued unmodified review conclusions.